Illumina, Inc. v. BGI Genomics Co., Ltd

Good Law
United States District Court, Northern District of CaliforniaAugust 11, 20203:19-cv-03770California2,264 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ILLUMINA, INC., et al., Case No. 19-cv-03770-WHO

Plaintiffs,

ORDER REGARDING MOTION FOR

v. STAY OF PRELIMINARY

INJUNCTION

BGI GENOMICS CO., LTD, et al., Re: Dkt. No. 202 Defendants.

Defendants BGI Genomics Co. Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc., and Complete Genomics, Inc. (collectively, “BGI”) move to stay or modify in part the preliminary injunction issued in this case pending their appeal to the Federal Circuit. Dkt. No. 202. I find that the balance of harms and the public interest weighs in favor of BGI and outweighs the likelihood of success on appeal of plaintiffs Illumina, Inc. and Illumina Cambridge Ltd. (collectively, “Illumina”). Accordingly, BGI’s motion is GRANTED as conditioned below. BACKGROUND Illumina filed the complaint in Case No. 19-cv-3770 (“Illumina I”) on June 27, 2019. Illumina I, Dkt. No. 1. It filed a motion for preliminary injunction in that case on…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.